Sequencing ALK inhibitors: alectinib in crizotinib-resistant patients, a phase 2 trial by Shaw et al

J Thorac Dis. 2016 Nov;8(11):2997-3002. doi: 10.21037/jtd.2016.11.76.
No abstract available

Publication types

  • Editorial
  • Comment